GANTRISIN
LOE ApproachingNDAORALSYRUP
Approved
Dec 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GANTRISIN is a legacy oral syrup antibiotic approved by Roche in 1953, representing a foundational small-molecule antimicrobial therapeutic. The drug's specific indications and mechanism of action are not currently documented in available data, though its historical approval and syrup formulation suggest use in bacterial infections, potentially including pediatric populations.
LOE Approaching
As a decades-old product approaching loss of exclusivity with moderate competitive pressure (30/100), the commercial team is likely small and focused on managed decline and legacy maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
GANTRISIN represents a legacy franchise with minimal career growth or expansion potential; roles are primarily operational and focused on maximizing remaining value and managing competitive decline. This product is unlikely to be a strategic driver for career advancement or team expansion at Roche.
Brand ManagerCommercial Operations Manager
Worked on GANTRISIN at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.